Steve Salop is a panelist on the topic entitled, “The New Administration – U.S. Global Antitrust Enforcement Going Forward.” CRA is also a sponsor.
For more information on this event, click here.
What’s 340B? An economist’s view of the recent wave of 340B litigation
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...
